Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Dividend Payout Ratio: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600566 Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
84 GF Score
Price ¥26.25
GF Value ¥21.00
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hubei Jumpcan Pharmaceutical Co Dividend Payout Ratio?

Hubei Jumpcan Pharmaceutical Co SHSE:600566 84 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates SHSE:600566 with a GF Score™ of 84/100 and a GF Value™ of ¥21.00 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 445 Drug Manufacturers companies, Hubei Jumpcan Pharmaceutical Co ranks worse than 92.58% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Hubei Jumpcan Pharmaceutical Co Ltd is 1.13, which seems too high.

The historical rank and industry rank for Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:600566' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26   Med: 0.52   Max: 1.23
Current: 1.13

During the past 13 years, the highest Dividend Payout Ratio of Hubei Jumpcan Pharmaceutical Co was 1.23. The lowest was 0.26. And the median was 0.52.

SHSE:600566's Dividend Payout Ratio is ranked worse than
92.58% of 445 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs SHSE:600566: 1.13

As of today (2026-07-19), the Dividend Yield % of Hubei Jumpcan Pharmaceutical Co is 6.63%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Hubei Jumpcan Pharmaceutical Co was 9.30%. The lowest was 1.35%. And the median was 2.91%.

Hubei Jumpcan Pharmaceutical Co's Dividends per Share for the months ended in Mar. 2026 was ¥0.00.

During the past 12 months, Hubei Jumpcan Pharmaceutical Co's average Dividends Per Share Growth Rate was 60.80% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 45.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 19.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 9.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hubei Jumpcan Pharmaceutical Co was 242.00% per year. The lowest was -42.00% per year. And the median was 3.85% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Hubei Jumpcan Pharmaceutical Co Dividend Payout Ratio Related Terms

Hubei Jumpcan Pharmaceutical Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Jumpcan Pharmaceutical Co Dividend Payout Ratio Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.30 0.30 0.53 1.23

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.87 0.00 0.00 0.00

SHSE:600566 vs ZTS, UTHR: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hubei Jumpcan Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio falls into.


SHSE:600566
84GF Score
Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hubei Jumpcan Pharmaceutical Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=2.09/ 1.7
=1.23

Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ 0.378
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Hubei Jumpcan Pharmaceutical Co (SHSE:600566) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. Over the past decade, Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.26 to 1.23. According to the industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #412 out of 445 companies in the Drug Manufacturers industry, placing it in the top 92.6%.
Is Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio too high?
Hubei Jumpcan Pharmaceutical Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 1.23. Based on the distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #412 out of 445 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hubei Jumpcan Pharmaceutical Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hubei Jumpcan Pharmaceutical Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #412 out of 445 companies for Dividend Payout Ratio. This places Hubei Jumpcan Pharmaceutical Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Hubei Jumpcan Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.26 to 1.23 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hubei Jumpcan Pharmaceutical Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Jumpcan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co (SHSE:600566) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥21.00, compared to a current price of ¥26.25 — trading 25% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Hubei Jumpcan Pharmaceutical Co's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Hubei Jumpcan Pharmaceutical Co (SHSE:600566), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Overvalued in 2026?

Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥26.25 is trading 25% above its estimated GF Value™ of ¥21.00. GuruFocus considers Hubei Jumpcan Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SHSE:600566:

  • Dividend Payout Ratio: 0.00
  • GF Value™: ¥21.00 vs. price of ¥26.25 (25% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hubei Jumpcan Pharmaceutical Co Business Description

Address Daqing West Road, Baota Bay, Jiangsu Province, Taixing, CHN, 225441
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemicals based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and Western medicines in the areas of pediatrics, gynecology, pneumonology, gastroenterology, and geriatrics. The company also develops Chinese and Western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
84GF Score

Get the complete analysis for SHSE:600566

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.25
Price
¥21.00
GF Value